moxonidine has been researched along with Autoimmune Diabetes in 1 studies
moxonidine: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strojek, K | 1 |
| Grzeszczak, W | 1 |
| Górska, J | 1 |
| Leschinger, MI | 1 |
| Ritz, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System[NCT03109795] | Phase 4 | 30 participants (Actual) | Interventional | 2017-04-10 | Terminated (stopped due to Funding ended) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for moxonidine and Autoimmune Diabetes
| Article | Year |
|---|---|
Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy?
Topics: Adult; Albuminuria; Animals; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic | 2001 |